Defibrillator Market Expected to Experience Steady Growth
by Matthew N. Skoufalos
There are two types of defibrillators – ICDs and AEDs. Both are life-saving devices and the market for these medical machines continues to grow.
The Mayo Clinic website describes an ICD or implantable cardioverter defibrillator as “a pager-sized device that’s implanted into your chest — may reduce your risk of dying if the lower chambers of your heart (ventricles) go into a dangerous rhythm and stop beating effectively (cardiac arrest). You may need an implantable cardioverter defibrillator if you have a dangerously fast heartbeat (ventricular tachycardia) or a chaotic heartbeat that makes it so your heart can’t supply enough blood to the rest of your body (ventricular fibrillation).”
The Mayo Clinic explains that, “Implantable cardioverter defibrillators work by detecting and stopping abnormal heartbeats (arrhythmias). An implantable cardioverter defibrillator continuously monitors your heartbeat and delivers extra beats or electrical shocks to restore a normal heart rhythm when necessary.”
An AED or automated exter-nal defibrillator is described by the American Heart Association as “a lightweight, portable device that delivers an electric shock through the chest to the heart. The shock can stop an irregular rhythm and allow a normal rhythm to resume in a heart in sudden cardiac arrest.”
TechNavio’s analysts forecast the global ICD market to reach $6.22 billion by 2015.
“One of the key factors contrib-uting to this market growth is the rising incidence of cardiovascular diseases. The global ICD market has also been witnessing the development of percutaneous and subcutaneous ICDs. However, the fall in prices of ICDs could pose a challenge to the growth of this market,” according to TechNavio.
“Sales of implanted defibrillators, which shock hearts to stop potentially deadly rhythm distortions, rose 3.5 percent to $713 million,” according to a Wall Street Journal article on Medtronic that was published Nov. 19, 2013.
Key vendors in this market space include Medtronic Inc., St. Jude Medical Inc., Boston Scientific Corp., and Sorin Group, according to a TechNavio report.
The AED market is expected to be worth $930 million by 2017, according to a report on MarketsAndMarkets.com.
“The global automated external defibrillator market was worth $616 million in the year 2012,” according to the report. “The market will grow at a healthy pace in the next five years due to the increasing incidence of cardiovascular disease, growing awareness about the life-saving potential of AED, increasing installation of public access AEDs, and technological advancements. Strategic collaborations, untapped emerging markets and home defibrillators represent vast opportunities for major shareholders of this market. However, frequent product recalls from various manufacturers and intense competition in mature markets will restrict the growth of the market, to some extent.”
MarketsAndMarkets.com indicated that North America is the largest market for AED, followed by Japan and Europe.
“The key players in the AED mar-ket are Philips Healthcare (The Netherlands), Cardiac Science (U.S.), ZOLL Medical Corporation (U.S.), Nihon Kohden (Japan), Phys-io-Control (U.S.), Defibtech (U.S.), HeartSine Technologies (U.S.), and Schiller (Switzerland),” according to the report.